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Abstract 
 
Femoral amputation is a devastating event. Percutaneous, bone anchored prosthetic systems 
reduce problems associated with socket suspended prostheses, but the design is inherently 
vulnerable to infection. The aims of this thesis were to determine the risk of implant-associated 
infection, bacterial biofilm properties and the functional impact using this implant treatment 
regime. Definition of implant related osteomyelitis was based on clinical signs, radiography and 
positive tissue cultures. In 3-year prospective study 39 patients were evaluated twice for infectious 
frequency, clinical presentation, and its relation to bacterial flora at the skin-implant interface 
(Paper 1). The frequency of implant infection was 5% at inclusion and 18% at follow-up. The 
most common bacteria in superﬁcial, and deep cultures were S. aureus and coagulase-negative 
staphylococci. Despite frequent colonization by potentially virulent bacteria, limited disability, 
and only one implant removal was found. Phenotypical and genotypical biofilm formation was 
determined in 13 (7 staphylococcal, 6 enterococcal) osteomyelitis strains (Paper II). 
Antimicrobial resistance was tested with a novel combination of the Calgary biofilm MBEC 
device, and a custom-made susceptibility MIC plate. The majority of the strains produced biofilm 
with increased antimicrobial resistance, compared to their planktonic counterparts. Slime 
producing strains tolerated higher antimicrobial concentrations compared to non-producers. All 
staphylococcal strains carried ica genes. The long-term risk of implant-associated infection, and 
its relation to patient and method specific factors was determined in a 20-year retrospective 
analysis of the first 96 femoral implant patients (102 implants) (Paper III). A 10-year cumulative 
risk of 20% for developing osteomyelitis (16 patients), and a 10-year cumulative risk of 9 % for 
implant extraction due to osteomyelitis (10 patients) was found. Antibiotic treatment (median 3.5 
months) and selective minor debridement, with retained implants, cured 7 out of 18 patients at the 
24-month follow-up (Paper IV). Six patients were cured after implant extraction, and 5 had 
chronic low-grade infections with stable implants, but variable use of the external prosthetic leg. 
The most common pathogens were S. aureus and E. faecalis. C-reactive protein serum levels were 
significantly higher in patients with osteomyelitis caused by S. aureus than other pathogens.  
 
It is concluded that the finding of an increased risk of osteomyelitis with time using this implant 
system calls for; i) careful patient selection and information of long term risks, ii) further studies 
on infection control, iii) consideration of biofilm in treatment, and iv) improved diagnostics, and 
antibiotic delivery.  
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